BIOSTEM TECHNOLOGIES INC (OTCMKTS:BSEM) had a decrease of 5.88% in short interest. BSEM’s SI was 1,600 shares in May as released by FINRA. Its down 5.88% from 1,700 shares previously. With 2,400 avg volume, 1 days are for BIOSTEM TECHNOLOGIES INC (OTCMKTS:BSEM)’s short sellers to cover BSEM’s short positions. It closed at $10.06 lastly. It is up 0.00% since May 1, 2017 and is . It has underperformed by 11.55% the S&P500.
Analysts expect ProntoForms Corporation (CVE:PFM) to report $-0.01 EPS on May, 10.They anticipate $0.00 EPS change or 0.00% from last quarter’s $-0.01 EPS. After having $-0.01 EPS previously, ProntoForms Corporation’s analysts see 0.00% EPS growth. The stock decreased 4.92% or $0.02 during the last trading session, reaching $0.29. About 20,000 shares traded. ProntoForms Corporation (CVE:PFM) has 0.00% since May 1, 2017 and is . It has underperformed by 11.55% the S&P500.
ProntoForms Corporation researches, develops, and markets mobile business software solutions for enterprises and businesses. The company has market cap of $31.96 million. The Company’s ProntoForms mobile platform automates business tasks through data access, collection, and delivery; connects and routes data across systems, cloud services, and people; and tracks and measures field activities to increase business performance. It currently has negative earnings. The firm also provides solutions for inspection and audit, installation and maintenance, and asset management.
BioStem Technologies, Inc. develops regenerative medicine in the United States, Europe, and South America. The company has market cap of $208,553. The Company’s services include nutritionist preparation comprising guided nutritional planning and preparation; conditional testing for allergens and cell optimization; and plasma replacement therapy. It currently has negative earnings. The company's areas of cell therapies comprise cardiovascular disease, arthritis, neuropathic pain, peripheral artery disease, sports and body injuries, and stroke.